The company started construction on the industrialization base project for slow-release drug formulations in July 2021. The base currently has a comprehensive formulation workshop, quality inspection center, comprehensive warehouse, chemical warehouse, and corresponding public auxiliary facilities. We have established a quality policy and quality management objectives that meet the requirements of drug quality management, and strictly operate the quality management system in accordance with the Drug Management Law and GMP requirements. The entire process of drug production, from design, research and development, production, inspection, quality control, release, etc., complies with GMP requirements.